B RILEY FINANCIAL INC - RILY 6 3/8 02/28/25 (RILYM)

US05580M8689

24.85  +1.26 (+5.34%)

After market: 24.81 -0.04 (-0.16%)

Fundamental Rating

2

Taking everything into account, RILYM scores 2 out of 10 in our fundamental rating. RILYM was compared to 222 industry peers in the Capital Markets industry. Both the profitability and financial health of RILYM have multiple concerns. RILYM has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year RILYM has reported negative net income.
In the past year RILYM had a positive cash flow from operations.
In multiple years RILYM reported negative net income over the last 5 years.
RILYM had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

RILYM has a worse Return On Assets (-3.49%) than 88.94% of its industry peers.
RILYM has a Return On Equity of -76.26%. This is amonst the worse of the industry: RILYM underperforms 94.47% of its industry peers.
With a Return On Invested Capital value of 1.95%, RILYM is not doing good in the industry: 70.51% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.49%
ROE -76.26%
ROIC 1.95%
ROA(3y)0.98%
ROA(5y)2.8%
ROE(3y)-2.83%
ROE(5y)10.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 8.23%, RILYM is doing worse than 76.50% of the companies in the same industry.
In the last couple of years the Operating Margin of RILYM has declined.
With a decent Gross Margin value of 67.58%, RILYM is doing good in the industry, outperforming 67.28% of the companies in the same industry.
RILYM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.23%
PM (TTM) N/A
GM 67.58%
OM growth 3Y-31.23%
OM growth 5Y-5.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-5.38%

0

2. Health

2.1 Basic Checks

RILYM has more shares outstanding than it did 1 year ago.
RILYM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RILYM is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.10, we must say that RILYM is in the distress zone and has some risk of bankruptcy.
RILYM's Altman-Z score of -0.10 is on the low side compared to the rest of the industry. RILYM is outperformed by 79.72% of its industry peers.
The Debt to FCF ratio of RILYM is 42.28, which is on the high side as it means it would take RILYM, 42.28 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 42.28, RILYM is doing worse than 60.37% of the companies in the same industry.
RILYM has a Debt/Equity ratio of 18.53. This is a high value indicating a heavy dependency on external financing.
RILYM has a worse Debt to Equity ratio (18.53) than 96.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 18.53
Debt/FCF 42.28
Altman-Z -0.1
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.22 indicates that RILYM may have some problems paying its short term obligations.
With a Current ratio value of 0.22, RILYM is not doing good in the industry: 86.64% of the companies in the same industry are doing better.
RILYM has a Quick Ratio of 0.22. This is a bad value and indicates that RILYM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of RILYM (0.18) is worse than 86.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.18

3

3. Growth

3.1 Past

RILYM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.84%.
Looking at the last year, RILYM shows a very strong growth in Revenue. The Revenue has grown by 31.31%.
The Revenue has been growing by 28.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-11.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-434.63%
Revenue 1Y (TTM)31.31%
Revenue growth 3Y18.88%
Revenue growth 5Y28.48%
Sales Q2Q%-15.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RILYM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RILYM is valued a bit cheaper than 72.81% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, RILYM is valued a bit cheaper than the industry average as 76.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.52
EV/EBITDA 16.81

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

RILYM has a Yearly Dividend Yield of 43.38%, which is a nice return.
RILYM's Dividend Yield is rather good when compared to the industry average which is at 9.70. RILYM pays more dividend than 99.54% of the companies in the same industry.
RILYM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 43.38%

5.2 History

On average, the dividend of RILYM grows each year by 43.04%, which is quite nice.
RILYM has been paying a dividend for over 5 years, so it has already some track record.
RILYM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)43.04%
Div Incr Years0
Div Non Decr Years3

5.3 Sustainability

The earnings of RILYM are negative and hence is the payout ratio. RILYM will probably not be able to sustain this dividend level.
DP-67.91%
EPS Next 2YN/A
EPS Next 3YN/A

B RILEY FINANCIAL INC - RILY 6 3/8 02/28/25

NASDAQ:RILYM (1/14/2025, 8:02:47 PM)

After market: 24.81 -0.04 (-0.16%)

24.85

+1.26 (+5.34%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-25 2024-11-25/amc
Earnings (Next)N/A N/A
Inst Owners34.83%
Inst Owner ChangeN/A
Ins Owners35.46%
Ins Owner ChangeN/A
Market Cap752.96M
Analysts0
Price TargetN/A
Short Float %3.49%
Short Ratio12.82
Dividend
Industry RankSector Rank
Dividend Yield 43.38%
Dividend Growth(5Y)43.04%
DP-67.91%
Div Incr Years0
Div Non Decr Years3
Ex-Date01-15 2025-01-15 (0.3984375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.54
P/FCF 7.52
P/OCF 7.02
P/B 3.3
P/tB N/A
EV/EBITDA 16.81
EPS(TTM)-3.61
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.3
FCFY13.3%
OCF(TTM)3.54
OCFY14.24%
SpS45.9
BVpS7.54
TBVpS-18.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -76.26%
ROCE 4.46%
ROIC 1.95%
ROICexc 2.03%
ROICexgc 2.5%
OM 8.23%
PM (TTM) N/A
GM 67.58%
FCFM 7.2%
ROA(3y)0.98%
ROA(5y)2.8%
ROE(3y)-2.83%
ROE(5y)10.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-40.96%
ROICexcg growth 5Y-5.6%
ROICexc growth 3Y-40.01%
ROICexc growth 5Y-4.61%
OM growth 3Y-31.23%
OM growth 5Y-5.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-5.38%
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 18.53
Debt/FCF 42.28
Debt/EBITDA 26.11
Cap/Depr 14.91%
Cap/Sales 0.51%
Interest Coverage 0.36
Cash Conversion 66.13%
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.18
Altman-Z -0.1
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)9.33%
Cap/Depr(5y)11.35%
Cap/Sales(3y)0.34%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-434.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.31%
Revenue growth 3Y18.88%
Revenue growth 5Y28.48%
Sales Q2Q%-15.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14211.5%
EBIT growth 3Y-18.25%
EBIT growth 5Y22.01%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.18%
FCF growth 3Y-32.92%
FCF growth 5YN/A
OCF growth 1Y35.95%
OCF growth 3Y-24.83%
OCF growth 5YN/A